Cargando…

Complete Resolution of Left Ventricular Outflow Tract Obstruction After Spontaneous Mitral Valve Chordal Rupture in a Patient With Hypertrophic Cardiomyopathy

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Ieki, Hirotaka, Mahara, Keitaro, Nagatomo, Yuji, Iguchi, Nobuo, Takayama, Morimasa, Isobe, Mitsuaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Chordal Rupture Resolves Heart Failure and Left Ventricular Outflow Obstruction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588837/ https://www.ncbi.nlm.nih.gov/pubmed/31286088 http://dx.doi.org/10.1016/j.case.2019.03.001

Ejemplares similares

Atrioventricular Shunt Post Acute Myocardial Infarction
por: Peters, Priscilla, et al.
Publicado: (2017)

Delayed Repercussions of Blunt Trauma: Isolated Muscular Ventricular Septal Defect
por: Al-Hijji, Mohammed A., et al.
Publicado: (2017)

Cryopreserved valved femoral vein homografts for right ventricular outflow tract reconstruction in infants
por: Sinha, Lok, et al.
Publicado: (2020)

Accuracy of the novel Peguero Lo‐Presti criterion for electrocardiographic detection of left ventricular hypertrophy in a black African population
por: Nyaga, Ulrich Flore, et al.
Publicado: (2021)

Development of a nomogram for screening the risk of left ventricular hypertrophy in Chinese hypertensive patients
por: Ye, Chaoyi, et al.
Publicado: (2021)

Comparison of the efficiency between electrocardiogram and echocardiogram for left ventricular hypertrophy evaluation in patients with hypertension: Insight from the Korean Hypertension Cohort Study
por: Park, Bo Eun, et al.
Publicado: (2022)

Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy
por: Bombelli, Michele, et al.
Publicado: (2023)

Deficiency of Tregs in hypertension‐associated left ventricular hypertrophy
por: Tang, Ying, et al.
Publicado: (2023)

Evaluation of the electrocardiogram RV(5)/V(6) criteria in the diagnosis of left ventricular hypertrophy in marathon runners
por: Yang, Pan, et al.
Publicado: (2023)

Prognostic implications of left ventricular hypertrophy defined by the thresholds from the international and Chinese guidelines
por: Zhou, Dan, et al.
Publicado: (2023)

The influence of aortoseptal angulation on provocable left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
por: Critoph, Christopher Howell, et al.
Publicado: (2014)

Geriatric Presentation of Idiopathic Left Ventricular Aneurysm
por: Dwivedi, Aeshita, et al.
Publicado: (2017)

Determinants of Functional Capacity and Quality of Life After Implantation of a Durable Left Ventricular Assist Device
por: Mirza, Kiran K, et al.
Publicado: (2020)

Chicago classification v4.0 protocol improves specificity and accuracy of diagnosis of oesophagogastric junction outflow obstruction
por: Visaggi, Pierfrancesco, et al.
Publicado: (2022)

Alcohol septal ablation markedly reduces energy loss in hypertrophic cardiomyopathy with left ventricular outflow tract obstruction: A four-dimensional flow cardiac magnetic resonance study
por: Dai, Zhehao, et al.
Publicado: (2021)

When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention
por: Iguchi, Moritake, et al.
Publicado: (2023)

Prognostic significance of repeated brain natriuretic peptide measurements after percutaneous transluminal septal myocardial ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy
por: Akita, Keitaro, et al.
Publicado: (2018)

Exercise and myocardial injury in hypertrophic cardiomyopathy
por: Cramer, G Etienne, et al.
Publicado: (2020)

Copper chelation in patients with hypertrophic cardiomyopathy
por: Reid, Anna, et al.
Publicado: (2022)

Significant reduction of left atrial volume concomitant with clinical improvement after percutaneous transluminal septal myocardial ablation for drug-refractory hypertrophic obstructive cardiomyopathy, and its precise detection with multidetector CT
por: Maekawa, Yuichiro, et al.
Publicado: (2016)

Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy
por: Ho, Jennifer E, et al.
Publicado: (2017)

Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity
por: de Feria, Alejandro E, et al.
Publicado: (2021)

Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy
por: Camaioni, Claudia, et al.
Publicado: (2020)

Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy
por: Salazar-Mendiguchía, Joel, et al.
Publicado: (2020)

Cardiovascular magnetic resonance T2* mapping for the assessment of cardiovascular events in hypertrophic cardiomyopathy
por: Gastl, Mareike, et al.
Publicado: (2020)

ECG characteristics according to the presence of late gadolinium enhancement on cardiac MRI in hypertrophic cardiomyopathy
por: Grall, Sylvain, et al.
Publicado: (2014)

Novel genotype–phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy
por: Lopes, Luis R, et al.
Publicado: (2015)

Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers
por: Adalsteinsdottir, Berglind, et al.
Publicado: (2020)

Functional, morphological and electrocardiographical abnormalities in patients with apical hypertrophic cardiomyopathy and apical aneurysm: correlation with cardiac MR
por: Suwa, Kenichiro, et al.
Publicado: (2014)

Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy
por: Sugrue, Alan, et al.
Publicado: (2017)

Prevalence of left ventricular dysfunction in a UK community sample of very old people: the Newcastle 85+ study
por: Yousaf, Fahad, et al.
Publicado: (2012)

Effect of Left Ventricular Assist Device Implantation and Heart Transplantation on Habitual Physical Activity and Quality of Life()
por: Jakovljevic, Djordje G., et al.
Publicado: (2014)

The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective
por: Griffiths, A, et al.
Publicado: (2014)

Referral for Specialist Follow-up and Its Association With Post-discharge Mortality Among Patients With Systolic Heart Failure (from the National Heart Failure Audit for England and Wales)
por: Emdin, Connor A., et al.
Publicado: (2017)

Obesity paradox in heart failure patients – Female gender characteristics-KAMC-single center experience
por: Khaled, Sheeren, et al.
Publicado: (2017)

Clinical and laboratory characteristics of short-term mortality in Egyptian patients with acute heart failure
por: Abdellah, Ahmad Tageldien, et al.
Publicado: (2017)

Effect of cardiac rehabilitation on cardiovascular risk factors in chronic heart failure patients
por: Mohammed, Haitham Galal, et al.
Publicado: (2018)

Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: Effect on thoracic fluid content
por: Ragab, Dalia, et al.
Publicado: (2018)

Myocardial performance index as an echocardiographic predictor of early in-hospital heart failure during first acute anterior ST-elevation myocardial infarction
por: Abuomara, Hossamaldin Zaki Alsayed, et al.
Publicado: (2018)

Assessment of right ventricular function by echocardiography in patients with chronic heart failure
por: William, Viola, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ma12kb1v7tjq5ou16d05totd6n